Portfolio Planning

Track readiness, milestones, and planning constraints across your project pipeline

Projects in Planning

vs. previous period

At Risk of Missing Milestones

vs. previous period

Milestones Due (Next 30 Days)

-1

vs. previous period

Avg Schedule Confidence (P80)

78%

+5%

vs. previous period

Milestone Timeline

April 2024

Line commissioningEquipment install+2 more

May 2024

Lab handoverValidation runs+1 more

June 2024

Design freezeManufacturing start+3 more

Planning Readiness

Ready: 16

At Risk: 6

Blocked: 2

Top Planning Blockers

Incomplete scope definition

8 projects

↑

Resource constraints

7 projects

→

Approval delays

6 projects

↓

Procurement long-leads

5 projects

↑

Design freeze pending

4 projects

→

Portfolio Projects

Project

Process Type

Next Milestone

Confidence

Blockers

Status

Owner

Fill Finish Line - Pharma A

Fill Finish

Line commissioning

15 Apr 2024

82%

Resources

On track

Sarah Chen

Drug Substance - Sanofi Paris

Drug Substance

Batch 3 manufacturing

22 Apr 2024

65%

ApprovalsDesign

At risk

Marc Dubois

Fill Finish - EMEA Biotech

Fill Finish

Equipment install

28 Apr 2024

71%

Procurement

At risk

Anna Mueller

Formulation Lab Upgrade

Formulation

Lab handover

05 May 2024

89%

None

On track

James Wilson

API Manufacturing - Asia

API

Validation runs

12 May 2024

58%

ScopeResources

Blocked

Priya Sharma

Portfolio Insights

!3 projects showing rising risk due to increased schedule variance since last revision. Review scope and resource plans.
✓Fill Finish and Formulation projects showing strong momentum with P80 confidence above 80%. Maintain current pace.
✕Milestone cluster in May indicates resource contention. Consider phased approach or cross-functional support.